Insulin Degludec/Liraglutide (Xultophy 100/3.6) for Type 2 Diabetes

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2017年 / 59卷 / 1529期
关键词：
FIXED-RATIO COMBINATION; LIRAGLUTIDE IDEGLIRA; EFFICACY; OUTCOMES; DEGLUDEC; TRIAL;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：147 / 149
页数：3
相关论文
共 50 条
  • [1] The Clinical Use of a Fixed-Dose Combination of Insulin Degludec and Liraglutide (Xultophy 100/3.6) for the Treatment of Type 2 Diabetes
    Harris, Kira
    Nealy, Kimberly Lovin
    ANNALS OF PHARMACOTHERAPY, 2018, 52 (01) : 69 - 77
  • [2] Insulin Degludec/Liraglutide: A Review in Type 2 Diabetes
    Sarah L. Greig
    Lesley J. Scott
    Drugs, 2015, 75 : 1523 - 1534
  • [3] Insulin Degludec/Liraglutide: A Review in Type 2 Diabetes
    Greig, Sarah L.
    Scott, Lesley J.
    DRUGS, 2015, 75 (13) : 1523 - 1534
  • [4] Insulin degludec/liraglutide (IDegLira) for the treatment of type 2 diabetes
    Gough, Stephen C. L.
    Jain, Rajeev
    Woo, Vincent C.
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2016, 11 (01) : 7 - 19
  • [5] Effectiveness of insulin degludec/liraglutide versus insulin degludec/insulin aspart in Japanese patients with type 2 diabetes
    Oya, Junko
    Nakagami, Tomoko
    Hasegawa, Yukiko
    Kondo, Yuichiro
    Katamine, Aki
    Shimizu, Mika
    Kubota, Ryo
    Suda, Rika
    Babazono, Tetsuya
    DIABETOLOGY INTERNATIONAL, 2024, 15 (02) : 237 - 243
  • [6] Effectiveness of insulin degludec/liraglutide versus insulin degludec/insulin aspart in Japanese patients with type 2 diabetes
    Junko Oya
    Tomoko Nakagami
    Yukiko Hasegawa
    Yuichiro Kondo
    Aki Katamine
    Mika Shimizu
    Ryo Kubota
    Rika Suda
    Tetsuya Babazono
    Diabetology International, 2024, 15 : 237 - 243
  • [7] Insulin degludec/liraglutide in type 2 diabetes: a profile of its use
    Heo, Young-A
    DRUGS & THERAPY PERSPECTIVES, 2020, 36 (06) : 219 - 229
  • [8] Insulin degludec/liraglutide in type 2 diabetes: a profile of its use
    Young-A Heo
    Drugs & Therapy Perspectives, 2020, 36 : 219 - 229
  • [9] Fixed Combination of Insulin Degludec and Liraglutide in Type 2 Diabetes Treatment
    Jaecke, E.
    Wilhelm, B.
    Kaiser, M.
    DIABETES STOFFWECHSEL UND HERZ, 2015, 24 (06): : 387 - 395
  • [10] Combination therapies in the management of type 2 diabetes: the use of insulin degludec/liraglutide
    Minze, Molly G.
    Chastain, Lisa M.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 471 - 478
12345